Literature DB >> 2904370

Incidence of aerobactin-positive Escherichia coli strains in patients with symptomatic urinary tract infection.

S H Jacobson1, M Hammarlind, K J Lidefeldt, E Osterberg, K Tullus, A Brauner.   

Abstract

A total of 323 Escherichia coli strains from children with primary acute non-obstructive pyelonephritis (n = 144) or cystitis (n = 56) and from adults with acute non-obstructive pyelonephritis (n = 66) or cystitis (n = 57) were examined for presence of the aerobactin-mediated iron uptake system and expression of P-fimbriae. Overall, pyelonephritogenic Escherichia coli strains were significantly more often aerobactin-positive (72%) than cystitis strains (42%) (p less than 0.001). Seventy-three percent of the isolates from children with acute pyelonephritis were aerobactin-positive compared to 54% of the cystitis strains (p less than 0.05). Pyelonephritogenic Escherichia coli strains from adults were also significantly more often aerobactin-positive (70%) than cystitis strains (30%) (p less than 0.001). The cystitis strains from children were more often aerobactin-positive than cystitis strains from adult patients (p less than 0.05). There was a significant correlation between presence of the aerobactin-mediated iron uptake system and expression of P-fimbriae in all strains (p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904370     DOI: 10.1007/BF01964240

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

Review 1.  Iron and infection.

Authors:  E D Weinberg
Journal:  Microbiol Rev       Date:  1978-03

2.  The effect of parenteral iron preparations on experimental pyelonephritis.

Authors:  J Fletcher; E Goldstein
Journal:  Br J Exp Pathol       Date:  1970-06

Review 3.  Microbial iron compounds.

Authors:  J B Neilands
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

Review 4.  The significance of iron in infection.

Authors:  J J Bullen
Journal:  Rev Infect Dis       Date:  1981 Nov-Dec

5.  Iron-suppressible production of hydroxamate by Escherichia coli isolates.

Authors:  S J Stuart; K T Greenwood; R K Luke
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Association of hydroxamate siderophore (aerobactin) with Escherichia coli isolated from patients with bacteremia.

Authors:  J Z Montgomerie; A Bindereif; J B Neilands; G M Kalmanson; L B Guze
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

7.  Rapid identification of P-fimbriated Escherichia coli by a receptor-specific particle agglutination test.

Authors:  S B Svenson; G Källenius; R Möllby; H Hultberg; J Winberg
Journal:  Infection       Date:  1982       Impact factor: 3.553

8.  P-fimbriated Escherichia coli in children with acute cystitis.

Authors:  K J Lidefelt; I Bollgren; G Källenius; S B Svenson
Journal:  Acta Paediatr Scand       Date:  1987-09

9.  Aerobactin-mediated iron uptake by Escherichia coli isolates from human extraintestinal infections.

Authors:  N H Carbonetti; S Boonchai; S H Parry; V Väisänen-Rhen; T K Korhonen; P H Williams
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

10.  Occurrence of P-fimbriated Escherichia coli in urinary tract infections.

Authors:  G Källenius; R Möllby; S B Svenson; I Helin; H Hultberg; B Cedergren; J Winberg
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

View more
  7 in total

1.  Production of cytotoxic necrotizing factor, verocytotoxin and haemolysin by pyelonephritogenic Escherichia coli.

Authors:  A Brauner; M Katouli; K Tullus; S H Jacobson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-10       Impact factor: 3.267

2.  Escherichia coli serotype O15:K52:H1 as a uropathogenic clone.

Authors:  G Prats; F Navarro; B Mirelis; D Dalmau; N Margall; P Coll; A Stell; J R Johnson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 3.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

4.  P fimbriation of Escherichia coli strains from patients with urosepsis demonstrated by a commercial agglutination test (PF TEST).

Authors:  U Kärkkäinen; R Ikäheimo; M L Katila; R Mäntyjärvi
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

5.  Ability of Pseudomonas pseudomallei malleobactin to acquire transferrin-bound, lactoferrin-bound, and cell-derived iron.

Authors:  H Yang; C D Kooi; P A Sokol
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

6.  Lack of association of Escherichia coli exhibiting both mannose-resistant haemagglutination and diffuse adherence to HEp-2 cells with acute diarrhoea in children.

Authors:  M Cobeljić; I Stojiljković; A Budisin; Z Lepsanović; N Lers
Journal:  Epidemiol Infect       Date:  1990-02       Impact factor: 2.451

7.  Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Authors:  Victor L Yu; Dennis S Hansen; Wen Chien Ko; Asia Sagnimeni; Keith P Klugman; Anne von Gottberg; Herman Goossens; Marilyn M Wagener; Vicente J Benedi
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.